Education
About Us
Working with TipRanks
Follow Us
Thyrocare Technologies Ltd (IN:THYROCARE)
:THYROCARE
THYROCARE Stock Chart & Stats
₹459.10
-₹16.20(-1.70%)
At close: 4:00 PM EST
₹459.10
-₹16.20(-1.70%)
Day’s Range― - ―
52-Week Range₹220.02 - ₹537.97
Previous CloseN/A
Volume114.81K
Average Volume (3M)56.30K
Market Cap
₹58.89B
Enterprise Value₹19.65B
Total Cash (Recent Filing)₹1.55B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)61.2
Beta0.47
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)4.30
Shares Outstanding159,161,700
10 Day Avg. Volume44,587
30 Day Avg. Volume56,302
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)2.35
Price to Sales (P/S)1.87
P/FCF Ratio8.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.1
Revenue Forecast (FY)₹8.17B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~21% revenue growth indicates durable demand for diagnostic testing and effective market penetration. As a centralized, automated lab operator, higher volumes improve capacity utilization and spread fixed costs, supporting scalable revenue conversion over the medium term.
Cash Flow GenerationRising operating cash flow and positive free cash flow growth improve financial flexibility for reinvestment in automation, lab upgrades and network expansion. Strong cash generation reduces reliance on external financing and supports sustainable operations and shareholder returns.
Balance Sheet StrengthA low debt-to-equity profile and improving equity ratio reduce financial risk and interest burden, enabling the company to fund strategic initiatives, absorb demand shocks, and pursue selective M&A or capacity builds without straining liquidity over the next several months.
Bears Say
Margin PressureA declining net margin suggests rising operating costs or pricing pressure that could erode profitability if persistent. Reduced margin conversion weakens the company's ability to translate revenue growth into durable earnings and could constrain reinvestment or return-of-capital plans.
High Capital ExpenditureSustained significant capex to expand or modernize labs supports growth but can pressure free cash flow if revenue ramps slow. Elevated investment needs raise execution risk and could limit near-term liquidity or capital available for other strategic uses.
Limited Investor CommunicationAbsence of earnings-call detail reduces visibility into management's forward guidance, margin drivers and strategic priorities. That governance and disclosure gap complicates assessment of medium-term execution risk and makes it harder to evaluate durable strategy outcomes.
Thyrocare Technologies Ltd News
THYROCARE FAQ
What was Thyrocare Technologies Ltd’s price range in the past 12 months?
Thyrocare Technologies Ltd lowest stock price was ₹220.02 and its highest was ₹537.97 in the past 12 months.
What is Thyrocare Technologies Ltd’s market cap?
Thyrocare Technologies Ltd’s market cap is ₹58.89B.
When is Thyrocare Technologies Ltd’s upcoming earnings report date?
Thyrocare Technologies Ltd’s upcoming earnings report date is May 21, 2026 which is in 72 days.
How were Thyrocare Technologies Ltd’s earnings last quarter?
Thyrocare Technologies Ltd released its earnings results on Jan 28, 2026. The company reported ₹4.3 earnings per share for the quarter, missing the consensus estimate of ₹4.5 by -₹0.2.
Is Thyrocare Technologies Ltd overvalued?
According to Wall Street analysts Thyrocare Technologies Ltd’s price is currently Overvalued.
Does Thyrocare Technologies Ltd pay dividends?
Thyrocare Technologies Ltd pays a Quarterly dividend of ₹2.333 which represents an annual dividend yield of 0.68%. See more information on Thyrocare Technologies Ltd dividends here
What is Thyrocare Technologies Ltd’s EPS estimate?
Thyrocare Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thyrocare Technologies Ltd have?
Thyrocare Technologies Ltd has 159,161,700 shares outstanding.
What happened to Thyrocare Technologies Ltd’s price movement after its last earnings report?
Thyrocare Technologies Ltd reported an EPS of ₹4.3 in its last earnings report, missing expectations of ₹4.5. Following the earnings report the stock price went up 1.313%.
Which hedge fund is a major shareholder of Thyrocare Technologies Ltd?
Currently, no hedge funds are holding shares in IN:THYROCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thyrocare Technologies Ltd
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Technical Analysis
Krsnaa Diagnostics Limited
―
Medi Assist Healthcare Services Limited
―
Metropolis Healthcare Ltd.
―
Morepen Laboratories Limited
―
Vijaya Diagnostic Centre Ltd.
―